Bezitramide

This classification denotes an analgesic agent with the molecular formula C31H32N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3KXW0Y310I, chemically known as 2-benzimidazolinone, 1-(1-(3-cyano-3,3-diphenylpropyl)-4-piperidyl)-3-propionyl- but generally known as bezitramide, which bears US NIH Compound Identifier 61791. European Medicines Agency schedules Bezitramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05811MIG. The term BEZITRAMIDE is an International Non-Proprietary Name. World Health Organization schedules bezitramide in its Anatomical Therapeutic Chemical (ATC) Classification. BEZITRAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bezitramide under HS 29333300 and SITC 51574. As of Q4 2014, BEZITRAMIDE remains the US FDA Preferred Term for this commodity. Bezitramide bears US NLM identifiers UMLS ID C0053535 and NCI Concept Code C72109. SMILES: O=C1N(C2CCN(CC2)CCC(C2CCCCC2)(C2CCCCC2)C#N)C2C(N1C(=O)CC)CCCC2.